. MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1. Clin Exp Pharmacol Physiol. 2020 Mar;47(3):372-382. Epub 2019 Dec 15 PubMed.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.